COMMUNIQUÉS West-GlobeNewswire

Tivity Health CEO Donato Tramuto Named Chairman of Robert F. Kennedy Human Rights Leadership Council
09/04/2018
Tramuto to lead national initiative on workplace dignity FRANKLIN, Tenn. and BOSTON, April 09, 2018 (GLOBE NEWSWIRE) -- Donato Tramuto has been named Chairman of the Leadership Council of Robert F. Kennedy Human Rights [...]
SuperSonic Imagine Showcasing Aixplorer Ultimate During the International Liver Congress (ILC) 2018
09/04/2018
SuperSonic Imagine will demonstrate the benefits of its Aixplorer Ultimate ultrasound system for the non-invasive assessment of chronic liver diseases AIX-EN-PROVENCE, France, April 09, 2018 (GLOBE NEWSWIRE) -- [...]
BioCorRx CEO Brady Granier and Legendary Soul Man Sam Moore Appear on Fox Business Network to Discuss the Company's Naltrexone Implant, Which Helps Combat Opioid Addiction
09/04/2018
ANAHEIM, CA, April 09, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady [...]
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
09/04/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 09 avril 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Ossur Hf : Transactions in relation to share buyback program
09/04/2018
Announcement no. 27/2018 Reykjavik, 09 April 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
Innovation Pharmaceuticals Phase 2 Oral Mucositis Trial Additional Data Show Brilacidin-OM Demonstrated A Significant Reduction in the Incidence of Severe Oral Mucositis in Patients with Head and Neck Cancer (HNC) Receiving Aggressive Chemotherapy Regimen
09/04/2018
BEVERLY, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report further data analysis from its successfully [...]
Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018
09/04/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ: SMMT ) will announce its financial results for the fourth quarter and fiscal year ended 31 [...]
Summit Therapeutics plc : Notice of Results
09/04/2018
Summit Therapeutics plc ("Summit", the "Company", or the "Group") Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018 Oxford, UK, and Cambridge, MA, US, [...]
Scythian Biosciences Corp. Announces Progression of Global Expansion Efforts with Letter of Intent to Acquire MMJ Colombia Partners Inc.
09/04/2018
– Closing of the Acquisition will strengthen Scythian’s Latin American platform with three Colombian cannabis licences including for cultivation of CBD, THC and extraction of cannabis derivatives – – Colombian native Mr [...]
Wildflower Re “Brands”
09/04/2018
VANCOUVER, British Columbia, April 09, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (the “Company”) held its Annual and Special Meeting on April 6 where shareholders overwhelming approved to change the [...]
Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension
09/04/2018
Pivotal Trial Now Underway to Study Effect of Investigational Procedure in Patients with High Blood Pressure DUBLIN - April 9, 2018 - Medtronic plc (NYSE: MDT ) today announced U.S. Food and Drug Administration (FDA) [...]
OrthoPediatrics Corp. Announces Sponsorship of 2018 EPOS Meeting and Lunch Symposium
09/04/2018
WARSAW, Ind., April 09, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it will continue its Diamond [...]
Canada House Announces Appointment of Chief Financial Officer
09/04/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) today [...]
Data Monitoring Committee (DMC) Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
09/04/2018
DMC Unanimously Recommends Continuation of OPTIMA Study Based on Safety Data From 411 Patients; Enrollment Now at 80% Blinded Progression-Free Survival (PFS) Rate in the OPTIMA Study is Consistent With the Subgroup [...]
Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary
09/04/2018
Richard Gabriel, BS, MBA is a board member of Precision Therapeutics and spearheaded the licensing of new technologies for 3D cell culturing from 48 Hour Discovery, SyntArray and CellBridge MINNEAPOLIS, April 09, 2018 ( [...]
Physeon Selects RCRI for Pivotal Study of Veinplicity Device
09/04/2018
Recent Clinical Trial Indicated Device had a Dilatory Effect 38% Greater than Standard of Care SCHAFFHAUSEN, Switzerland, April 09, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer [...]
Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder
09/04/2018
Multi-center trial to enroll approximately 324 patients at approximately 40 clinical sites in U.S. and Europe WALTHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical- [...]
EyeGate Receives FDA Feedback on Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
09/04/2018
Feedback Provides Clear Path to Resubmission; Expected July 2018 WALTHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty [...]
OncoMed to Present Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer Research Annual Meeting
09/04/2018
REDWOOD CITY, Calif., April 09, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED ), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]

Pages